Posted on Leave a comment

Seven herbal medicines can kill Lyme disease bacteria in test tube – LymeDisease.org

Researchers have determined that seven herbal medicines are highly active in test tubes against B. burgdorferi, the bacteria that causes Lyme disease, compared to the control antibiotics, doxycycline and cefuroxime.
Published in the journal Frontiers in Medicine, the laboratory study was funded by the Bay Area Lyme Foundation and supported in part by The Steven & Alexandra Cohen Foundation.
Researchers at Johns Hopkins Bloomberg School of Public Health and colleagues at the California Center for Functional Medicine and FOCUS Health Group, Naturopathic collaborated on the study.
“Since traditional antibiotic approaches fail to resolve symptoms in up to 25% of patients treated for Lyme disease and many suffer disabling effects of the disease, there is a need for novel treatment proven effective against B. burgdorferi,” said the paper’s co-author Sunjya K. Schweig, MD, CEO and co-director, California Center for Functional Medicine and Scientific Advisory Board Member, Bay Area Lyme Foundation.
“Because patients are currently turning to herbal remedies to fill the treatment gaps left by antibiotics, this research is a critical step in helping clinicians, as well as patients, understand which ones may offer the most potential benefit.”
According to this study, carried out by Prof. Ying Zhang’s group at the Johns Hopkins Bloomberg School of Public Health, the seven herbal medicines that have the ability to kill B. burgdorferi in test tubes are:
It is important to note that each of these products have the potential to produce significant side effects in patients, and should be taken only under advisement of a clinician knowledgeable of their capabilities and toxicities.
Of these products, the Cryptolepis sanguinolenta extract caused complete eradication, while doxycycline and cefuroxime and other active herbs did not. This extract has been used for the treatment of malaria as well as the tick-borne infection Babesia, a malaria-like parasite.
This study is believed to be the first time this extract has been documented to have a potential impact on B. burgdorferi, and additional laboratory and clincial studies should be conducted to investigate the potential role Cryptolepis sanguinolenta could play in the treatment of Lyme disease.
Further, Cryptolepis sanguinolenta and Polygonum cuspidatum (Japanese knotweed) showed strong activity against both growing B. burgdorferi (MIC=0.03%-0.06% and 0.25%-0.5% respectively) and non-growing stationary phase B. burgdorferi.
In contrast, Stevia rebaudianaAndrographis paniculata, Grapefruit seed extract, colloidal silver, monolaurin, and antimicrobial peptide LL37 had little or no activity against stationary phase B. burgdorferi.
“Our hope is that findings from this study could point to new therapeutic options for doctors and their patients, and pave the way for clinical research to help patients with persistent Lyme disease,” said Linda Giampa, executive director, Bay Area Lyme Foundation.
These data may provide a basis for the clinical improvement of patients who take herbal medicines, particularly those whose chronic symptoms may be due to persistent bacteria that are not killed by conventional Lyme antibiotic treatment.
However, it is critical to note that additional studies are needed to further evaluate the seven active botanical medicines identified in the study. Patients should not attempt to self-treat with these herbal medicines due to potential side effects and lack of clinical trials with these products.
For the study, the researchers tested 14 natural products in test tubes against B. burgdorferi. Plant extracts selected for the study included herbs or agents that: have been previously used to manage the symptoms of patients who do not respond to standard Lyme antibiotic treatment; have favorable safety profiles; and can be absorbed systemically.
Additional criteria for selecting compounds included anti-biofilm effects and ability to cross the blood-brain barrier. To conduct the study, the plant extracts in concentrations of 1%, 0.5% and 0.25% and antibiotic controls were each tested on growing as well as non-growing B. burgdorferi cultures.
The study found that seven of these natural product extracts at 0.25%-0.5% had better activity against the stationary phase B. burgdorferi culture than the control antibiotics doxycycline and cefuroxime, both of which are commonly used to treat Lyme disease.
The paper titled “Evaluation of Natural and Botanical Medicines for Activity against Growing and Non-growing Forms of B. burgdorferi,” was written by Jie Feng, PhD, Jacob Leone, ND, Sunjya Schweig, MD, and Ying Zhang, MD, PhD.
PRESS RELEASE SOURCE: Bay Area Lyme Foundation
LymeDisease.org is a non-profit
501(c)(3) that serves the patient community through advocacy, education and research.
Federal EIN-68-0214101
Support LymeDisease.org
Become a member.
Comments? Questions?
Ask your questions here.
LymeDisease.org
PO Box 16009 | San Diego, CA 92176

source

Posted on Leave a comment

Top 7 Crypto Assets To Buy In November 2025 Based On Current Market Trends – Outlook India

Get magazine delivered to your doorstep
Get latest issue delivered instantly
Only in Delhi-NCR, Mumbai, Bengaluru, Pune, Lucknow & Kolkata
Get magazine delivered to your doorstep
Get latest issue delivered instantly
Only in Delhi-NCR, Mumbai, Bengaluru, Pune, Lucknow & Kolkata
The current state of the cryptocurrency market is unusual. Many digital assets are caught between a fading crypto bear market and the next potential crypto bull run. Prices are volatile, and market sentiment is conflicted. For smart crypto investors, this is often the best time to study real crypto trends, not hype. Based on current crypto news, institutional adoption, and on-chain activity, these seven assets stand out as some of the best crypto to buy now in November 2025or at least to keep on a serious watchlist.

Source: Bitbull
Bitcoin is retesting the 90,000 dollar support level, a key zone in its larger trading channel that also lines up with the value area low on high time frames. This level marked the last major bottom, and the current structure once again hints at a possible swing reversal. If Bitcoin can hold above 90,000 dollars, a rotation toward 135,000 dollars becomes more likely, while a clean break below the channel low would weaken that bullish case and add more market volatility.
Macro factors are vital alongside technical analysis in the crypto market, with upcoming US regulations potentially fostering institutional interest. Key developments include New Hampshire’s $100 million municipal bond using Bitcoin, the Lightning Network allowing fee-free payments for millions until 2027, and Adam Back’s push for post-quantum security. Despite a $303.8 million drop attributed to strict macroeconomic conditions and institutional exits, Bitcoin continues to be a cornerstone of the crypto market.

Source: TradingView
Solana has slipped around 13.3 percent over the last seven days and about 11.8 percent over the last 14 days, with the price moving between 137 and 142.84 dollars before settling near 138.33 dollars. On lower time frames, the chart still shows a clear downtrend within Fibonacci retracement levels, but the recent bounce and a market cap above 77 billion dollars suggest a possible bottoming process. This kind of move is common in altcoins during uncertain market sentiment.
At the same time, crypto analysis around Solana is changing because of strong ETF momentum. Solana exchange-traded products have been promoted by Fidelity, Bitwise, VanEck, Canary Funds, and 21Shares. If the next stage of the cryptocurrency market turns risk on once more, a number of Solana ETFs on significant platforms like Nasdaq provide institutions with an easier way to enter the market, which could support liquidity, on-chain activity, and wider adoption of cryptocurrencies.

Source: TradingView
After a fake breakout above 3,124 dollars, Ethereum is now trading near 3,059 dollars, and short-term charts may indicate a possible test of support at 2,959 dollars. The price can shift towards the 2,800-2,900 dollar range in case the daily candles start closing around or below this mark. Traders are keeping an eye on $3,004 as a key line from a mid-term perspective. For leveraged traders, risk remains high because a breakdown here might release enough energy for a larger move lower.
Ethereum continues to be the hub of smart contracts, decentralised finance (DeFi), and numerous Web3 dApps despite this price pressure. The goal of the new Interop Layer is to improve user experience, liquidity, and staking flows across rollups by streamlining cross-Ethereum Layer 2 interactions. Ethereum remains at the core of blockchain technology for long-term cryptocurrency investors who are interested in tokenomics, network effects, and DeFi infrastructure.

Source: Ali Martinez
Cardano has dropped hard, briefly tagging 0.45 dollars before recovering to around 0.4690 dollars. It is down more than 16 percent over the last week and over 30 percent across 30 days, making it one of the more beaten-down altcoins in this group. This kind of deep drawdown often scares short-term traders, but it can also reset valuations in a way that attracts patient investors who study the crypto market rather than daily noise.
Analysts are divided on Cardano’s next move, with one suggesting a potential 97% rally to around 1.10 dollars based on RSI patterns, while more conservative views target a drop to 0.65 dollars if accumulation continues and resistance levels break. Santiment data signals recovery potential due to a negative MVRV ratio. The upcoming launch of the Midnight sidechain and its NIGHT token aims to enhance privacy in smart contracts while adhering to crypto regulations, potentially bolstering Cardano’s position in the next crypto bull market.

Source: DevKabib
Chainlink is currently finding it difficult to surpass the 14-dollar mark; however, analysis from CryptoQuant indicates increased LINK outflows from Binance, especially in large transactions, hinting at accumulation by whale investors. Average daily outflows are about 3,150 LINK, demonstrating rising confidence in the market’s potential changes.
At the same time, Chainlink is improving practical applications, collaborating with Mastercard to facilitate on-chain cryptocurrency payments, and putting its Proof of Reserve into practice to guarantee transparency for tokenized assets and stablecoins. These developments, which establish Chainlink as an essential infrastructure element in the cryptocurrency industry, include security innovations through decentralised knowledge graphs and enhanced secret management.

Source: TradingView
After moving between $886.57 and $923.98 over the past day, BNB is currently trading at about $890. It has lost roughly 1.5% for the day, 5.6% over the previous week, and 2.7% over the previous 14 days, all of which are in line with a larger pattern of modest declines in significant digital assets. With resistance at the Tenkan sen ($952.67) and Kijun sen ($1,033.50), the daily chart shows a bearish structure for BNB. Regaining these levels is essential to the token’s potential rise above $1,100.
Additionally, BNB’s narrative is strongly linked to institutional adoption and tokenization, highlighted by BlackRock’s BUIDL Fund. This initiative aims to integrate traditional finance with DeFi tools using tokenized liquidity, enhancing interactions for users of Binance’s trading platform. As such, BNB is a critical asset for investors focusing on crypto exchanges and tokenized funds.

Remittix takes a different route from many altcoins on this list by focusing on PayFi, the bridge between crypto and traditional finance. The project will make it easy to convert cryptocurrency into fiat and vice versa, through a single seamless application that would coordinate conversions, payments, and international transfers. Remittix is attempting to integrate blockchain technology into regular payment flows rather than merely following price movements on charts, which, if successful, could aid in long-term cryptocurrency adoption.
The team has already raised over 28.1 million dollars through the sale of more than 686 million RTX tokens at 0.1166 dollars each, which is a strong sign of interest in a cautious market. The wallet is already in beta, with regular updates shaped by real community feedback, showing that Remittix is shipping product, not just writing plans. The project has also been audited by CertiK, with a verified team and checked smart contracts, which is important for investors who care about security, trust, and clear crypto analysis.
Multiple CEX listings are secured, including BitMart, with larger exchange partnerships planned as future milestones are reached. By targeting the 19 trillion dollar global payments market instead of only on chain trading, Remittix positions itself as a cryptocurrency with real-world utility rather than pure speculation. For investors who want exposure to the growth of digital payments as well as the wider crypto market, RTX offers a very different angle from the usual smart contract or meme coin story.
The Bitcoin, Solana, Ethereum, Cardano, Chainlink, and BNB are the key players in the cryptocurrency market. They influence such trends as tokenisation, adoption by institutions, ETFs, DeFi, and privacy smart contracts. These cryptocurrencies can be the cornerstone of long-term investment portfolios and are essential for both the impending stages of the cryptocurrency bull and bear markets in November 2025.
Due to its focus on PayFi infrastructure, audited smart contracts, operational wallet beta, and listings on centralised exchanges (CEX), Remittix stands out among current offerings as a compelling investment option. With a focus on the $19 trillion payments sector, Remittix provides a substantial use case linking cryptocurrency to real-world economic activities. Despite inherent project risks, its blend of utility, development, and potential growth aligns well with the future landscape of decentralized finance and the movement of global money.
1. What is the best cryptocurrency to buy at the moment?
No single best solution fits all investors because each one of them has a different risk profile and a different time horizon. This is where many start with large holdings of Bitcoin and Ethereum and then add altcoins that solve real problems of Web3, DeFi, or payments. To strike a compromise between growth opportunity and practical use, certain investors have come to pair older names with recent PayFi projects, such as Remittix, that connect digital assets to bank-like payments.
2. Should we invest in crypto now?
Only when you know that prices remain volatile and can change sharply in either direction. A cautious strategy would include investing in projects with good tokenomics, good development, and evident use cases, and investing in dollar cost averaging instead of lump sums. Another way to avoid impulsive actions is to investigate the news of cryptocurrency, regulations, and the overall mood on the market.
3. What influences cryptocurrency price changes?
The prices of cryptocurrencies are affected by such factors as macroeconomic data, the variation of interest rates, new regulations of the crypto industry, and significant news events, to name a few. It is also possible to move supply shifts, staking yields, on-chain activity, and liquidity on DEX and CEX markets. Hacks, lawsuits, or exchange issues are likely to cause fear and selling, whereas good news like ETF launches, major partnerships, or new technology is likely to trigger a rally.
4. Is Remittix a great long-term investment?
Remittix can be of interest to investors who believe that the next phase in the expansion of cryptocurrencies is going to be pushed by real payments in addition to trading. It has a focus on a full PayFi stack, audited smart contracts, verified CEX listings, and a working wallet beta as positive indicators. It is reasonable to expect to treat it as a diversified portfolio containing larger, established, digital assets since it also has risk, just as any early-stage project.
5. What can I do to prevent scams when researching new projects to invest in?
Rather than concentrating on aggressive marketing or unreasonable promises, seek real products, dynamic progress, and constant contact via the publicity channels. Be careful when handling projects with high turnaround and promise returns. The new tokens can be compared with Remittix, which publishes audits and reflects real progress, which helps to detect warning signs much faster.
Discover the future of PayFi with Remittix by checking out their project here:
Website: https://remittix.io/
Socials: https://linktr.ee/remittix
$250K Giveaway: https://gleam.io/competitions/nz84L-250000-remittix-giveaway
Disclaimer: Cryptocurrency investments are risky and highly volatile. This is not financial advice; always do your research. Our editors are not involved, and we do not take responsibility for any losses.
Click/Scan to Subscribe
WATCH | Subir Sinha Raises Questions Over Anomalies in Bihar Election Counting
Video | Nowgam Police Station Blast: 9 Dead in Accidental Srinagar Explosion During Handling of Seized Explosives
Watch | Red Fort Blast 2025: J&K Police Arrest Al-Falah University Doctor And Pulwama Resident In Ongoing Investigation
Watch | Dashrath Manjhi Cut A Mountain For 22 Years, His Family Got Nothing | Bihar Elections
LivLive ($LIVE) Black Friday Sale: 300% Presale Bonus – Is It The Best Deal Over SpacePay ($SPY) And IPO Genie ($IPO)?
Lab-Grown Diamonds In India: How Pure Jewels Is Leading A Quiet Revolution
Unimeal App Review 2025: Honest Verdict — Is It Scam
Are We Doing Enough To Screen Crypto-To-Crypto Trades?
Is NFT Marketplace Data The Key To Understanding The Future Of Digital Assets?
Day In Pics: November 22, 2025
IND Vs SA, 2nd Test: India End Day 1 On Top As Proteas Fail To Get Start
AUS Vs ENG 1st Test, Ashes: Head’s Century Seals Two-Day Eight-Wicket Win For Aussies
NBA 2025-26: Suns Stun Timbewolves In Last Minute Victory
DMCA.com Protection StatusCopyright © 2025 Outlook Publishing India Pvt Ltd.
DMCA.com Protection Status

Copyright © 2025 Outlook Publishing India Pvt Ltd. All pages of the Website are subject to our terms and conditions and privacy policy. You must not reproduce, duplicate, copy, sell, resell or exploit any material on the Website for any commercial purposes.

source

Posted on Leave a comment

Crypto Panic : $800B Wiped Out In Weeks – Cointribune

                            <a href="https://www.cointribune.com/en/profile/" target="" class="">🎁 Discover our latest Read2Earn quests and earn by reading 🎁</a>                            <br><span><span><a href="https://www.cointribune.com/en/">Home</a></span> » <span><a href="https://www.cointribune.com/en/news/">News</a></span> » <span><a href="https://www.cointribune.com/en/news/crypto-news/">Crypto News</a></span></span><br>The crypto market is going through an unstable period, marked by a sharp decline in the most speculative assets. In 24 hours, memecoins lost more than 5 billion dollars, bringing their capitalization to an annual floor. NFTs follow the same trajectory, reaching their lowest level since April. This plunge is part of a broader flight-to-safety movement, with investors massively deserting high-risk assets.<br>While many analysts see <a href="https://www.cointribune.com/en/galaxy-research-exposes-the-hidden-memecoin-machine/" target="_blank" rel="noreferrer noopener">these cryptos as a lucrative bubble for platforms</a>, memecoins reached their lowest level of the year this Friday, November 21, with total capitalization brought down to 39.4 billion dollars.<br>This number marks a drop of 66.2 % from the peak of 116.7 billion dollars recorded on January 5. In just 24 hours, <a href="https://coinmarketcap.com/view/memes/" target="_blank" rel="noreferrer noopener">more than 5 billion dollars were wiped out from the market</a>, despite a notable 40 % increase in trading volume.<br>This dynamic is part of a general correction context. Thus, the overall crypto market capitalization went from 3,770 billion dollars at the beginning of November to 2,960 billion on November 21, a loss of 800 billion dollars in three weeks.<br>The top ten memecoins have all been impacted, without exception, showing short- and medium-term losses. Currently, none manages to stay in the green, all indicators pointing downwards. Here are <a href="https://cointelegraph.com/news/memecoins-nfts-hit-lowest-2025-crypto-market-selloff" target="_blank" rel="noreferrer noopener">the key elements</a> :<br>This widespread decline is nevertheless accompanied by growing activity, with an explosion in trading volumes, a possible sign of massive investor disengagement.<br>All these elements testify to a sharp disinterest in speculative assets, in a context of increased crypto market volatility. The severity and speed of this correction signal a strengthened risk aversion climate, likely to reshape investor priorities in the coming weeks.<br>Alongside the collapse of memecoins, the NFT market is going through a period of sharp contraction. The capitalization of non-fungible tokens dropped to 2.78 billion dollars on November 21, compared to 4.9 billion thirty days earlier.<br>This is the lowest valuation recorded since last April. This 43 % decline in one month confirms a growing disinterest from investors for collectible cryptos, whose speculative cycle seems to be slowing down.<br>Most major collections are affected. Hyperliquid’s Hypurr NFTs show a spectacular drop of 41.1 % over 30 days. Moonbirds fall 32.7 %, CryptoPunks 27.1 %, while Pudgy Penguins lose 26.6 % of their value.<br>Two exceptions stand out however: Infinex Patrons rise 11.3 % over the past month, while Autoglyphs limit the damage with a slight decline of 1.9 %. These isolated performances are nevertheless not enough to reverse the overall trend.<br>Unlike memecoins, which are affected by short-term market dynamics, the drop in NFTs seems to fit into a more structural trajectory, marked by a lasting decline in interest for this type of asset.<br>While the current correction reflects a form of market consolidation, it raises questions about the sustainability of certain segments of Web3. The frenzied speculation that propelled these assets in 2021–2022 appears to have lost momentum. Some analysts will see this as a necessary purification phase, while others as a deeper repudiation.<br>Maximize your Cointribune experience with our "Read to Earn" program! For every article you read, earn points and access exclusive rewards. Sign up now and start earning benefits.<br>Diplômé de Sciences Po Toulouse et titulaire d'une certification consultant blockchain délivrée par Alyra, j'ai rejoint l'aventure Cointribune en 2019.  Convaincu du potentiel de la blockchain pour transformer de nombreux secteurs de l'économie, j'ai pris l'engagement de sensibiliser et d'informer le grand public sur cet écosystème en constante évolution. Mon objectif est de permettre à chacun de mieux comprendre la blockchain et de saisir les opportunités qu'elle offre. Je m'efforce chaque jour de fournir une analyse objective de l'actualité, de décrypter les tendances du marché, de relayer les dernières innovations technologiques et de mettre en perspective les enjeux économiques et sociétaux de cette révolution en marche.<br>The views, thoughts, and opinions expressed in this article belong solely to the author, and should not be taken as investment advice. Do your own research before taking any investment decisions.<br>Receive the latest and best crypto news directly to your inbox<br>in daily, weekly, or special format, to stay updated at your own pace<br>Receive the latest and best crypto news directly to your inbox<br>in daily, weekly, or special format, to stay updated at your own pace<br><br><a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxPeGgwa3ItSTRuQ0dMSklUZmFIakVLU3lkV1NuLVNmSEtYWXVPQXV0WllSd0h6bUV5RWNGZUsxbFZmUENid3RVSV93TGhTV0tPaVFSbHBDNXZnaTM0dXE1cE9sQ0FKN29DTlV3RVZOLXNXMG56WXJfS281alh1VXNsMURxMU9KLUhj?oc=5">source</a>